Humana Stock Price and Value Analysis

Should you buy Humana stock? (NYSE:HUM). Let's see how it does in our automated value investing analysis system.

  • This company is very stable.
  • This company has wild ups and downs.
  • This company has a low dividend yield.
  • This stock looks overpriced.
  • This company is not making money.

HUM Free Cash Flow Trend

Hmm, we can't give any reliable projection for Humana's growth rate. The company either has too few years of historical data for us to examine, or it's in the habit of losing money.

None of this means it's a bad stock. Maybe it's new and growing quickly, or maybe it's turning things around. We can't say anything sensible about it, so we won't say it's obviously undervalued right now. Proceed at your own risk!

Free Cash Flow trendline for HUM
Free Cash Flow trendline for Humana

Inside the HUM Numbers

HUM Price
(Humana stock price per share)
[?] PE Ratio versus Sector 15% lower than other Healthcare stocks
[?] PE Ratio versus Industry 44% higher than other Health Care Plans stocks
[?] Cash Yield 0.88%
[?] Free Cash Flow Jitter 36%
[?] Dividend Yield 1%

Is Humana Stock on Sale?

Based on our analysis, we believe that you should not buy Humana right now. It might be a good stock to own—we just can't prove it with value analysis right now. Proceed with caution.

Should You Buy HUM Stock?

Does Humana have a coherent story? Does it have a plan to continue to make money? Is it worth your time? Only you can decide where to go from here. Our investment guide helps you ask the right questions, including how to buy stocks. Use these research links for more information.